{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-059893","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2024-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.891395+00:00","generated_at":"2026-06-02T04:25:03.113998+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Applied DNA Q2 revenue down 79% to $930k; operating loss widens to $3.6M","bullets":["Total revenue $930k vs $4.4M YoY; COVID testing contract with CUNY ended June 2023.","Gross profit declined to $296k (32% margin) from $1.8M (41%) YoY.","Operating loss $3.6M vs $2.7M YoY; adjusted EBITDA -$3.3M.","Cash $3.1M as of March 31, 2024, down from $7.2M at Sept 30, 2023.","Effected 1-for-20 reverse stock split on April 25, 2024; regained Nasdaq bid price compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-059893","json":"https://secwatch.observer/filing/0001104659-24-059893.json","markdown":"https://secwatch.observer/filing/0001104659-24-059893.md","text":"https://secwatch.observer/filing/0001104659-24-059893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465924059893/0001104659-24-059893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465924059893/tm2414131d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:25:03.113998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c1610cd07906833bd7b0f210db2fb2093a3fa0a","claim":"BNB PLUS CORP. reported second fiscal quarter ended March 31, 2024 results: revenue approximately $930 thousand.","evidence_excerpt":"reporting period. The Company will host an investor update call on June 12, 2024. Summary Second Quarter Fiscal 2024 Financial Results: ● Total revenues were approximately $930 thousand for the three-month period March 31, 2024, compared to $4.4 million for the second quarter of fiscal 2023. The decrease in revenue of approximately $3.5 million was due to an","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744452/000110465924059893/0001104659-24-059893-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second fiscal quarter ended March 31, 2024"},{"label":"Revenue","value":"approximately $930 thousand"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}